MarketInOut Stock Screener Log In | Sign Up

Alpha Tau Medical Ltd

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Alpha Tau Medical Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,207.76 mln
Float74.16 mln
Earnings Date11/24/2026

Piotroski F-Score

3 / 9
Below average

Relative Strength

87 / 100
Strongly outperforming

Debt / Equity

0.34
Low leverage

ROE

-130
Deeply negative

ROA

-81.89
Deeply negative

Business Description

Alpha Tau Medical is an Israel-based medical company developing a new type of radiation treatment for solid tumors called Alpha DaRT. The therapy works by placing small radioactive seeds directly into a tumor, where they release high-energy alpha particles to destroy cancer cells. The company is currently testing this approach in clinical trials across a wide range of cancer types, including skin, prostate, pancreatic, lung, liver, and breast cancers.

Key Fundamentals

EPS-1.04
ROE-130
ROIC-176
ROA-81.89
Interest Cover-1.22
EBITDA, mln-50.96
EV / EBITDA-22.34
EV / EBIT-22.34

Quote Details

Last 13.06
Change -0.17 (-1.28%)
Open 12.85
Volume 475,222
Turnover 6,206,400
Average Volume 464,640

Financial Ratios

Leverage Ratio3.05
Current Ratio11.09
Price / Book28.15
Price / Tangible Book28.15
Debt / Equity0.34

Financial Strength

Piotroski F-Score 3 / 9
Short Ratio7.22
Short % of Float5.35

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.76% 40 / 100   
1 Month -9.99% 29 / 100   
2 Months 6.96% 85 / 100   
6 Months 52.93% 96 / 100   
1 Year 219% 99 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog